Our leadership team is united by an unwavering commitment to creating value through the development of innovative new therapies to improve the treatment of cancer. Bringing together years of industry experience, our dedicated team shares the same vision to create therapies that make a meaningful difference in the lives of patients.
Michael M. Morrissey, Ph.D.
President and Chief Executive Officer
Vice President and Interim Chief Financial Officer
J. Scott Garland
Executive Vice President and Chief Commercial Officer
Jeffrey J. Hessekiel, J.D.
Executive Vice President and General Counsel
Peter Lamb, Ph.D.
Executive Vice President, Discovery Research and Chief Scientific Officer
Gisela M. Schwab, M.D.
Executive Vice President and Chief Medical Officer